Lupin logo

LUPIN - Lupin News Story

₹1079.45 30.2  2.9%

Last Trade - 09/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £4.78bn
Enterprise Value £4.99bn
Revenue £1.49bn
Position in Universe 83rd / 3106

BRIEF-Lupin Gets Nod For Sulfamethoxazole And Trimethoprim Oral Suspension

Wed 6th January, 2021 10:30am
Jan 6 (Reuters) - Lupin Ltd  LUPN.NS :
    * LUPIN RECEIVES APPROVAL FOR SULFAMETHOXAZOLE AND
TRIMETHOPRIM
ORAL SUSPENSION USP

Source text for Eikon:  ID:nBSE4gZQTn 
Further company coverage:  LUPN.NS 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.